| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology, Mayo Clinic and Foundation, Rochester, Minnesota 55905 [G. P., M. J. S., C. G., D. M., J. R.], and Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118 [E. J. M.]
The ether lipid analogue 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3) has been shown to be a direct inhibitor of Swiss 3T3 fibroblast and BG1 ovarian adenocarcinoma cell cytosolic phosphoinositide selective phospholipase C (PIPLC) using [3H]-phosphatidylinositol-(4, 5)-bisphosphate ([3H]PIP2) as the substrate. The inhibition occurred when ET-18-OCH3 was incorporated into the [3H]PIP2 substrate micelles, with 50% inhibition (IC50) occurring at a ET-18-OCH3: [3H]PIP2 ratio of 0.04, or an assay concentration of 0.4 µM, and when ET-18-OCH3 was added directly to the incubation, with an IC50 of 9.6 µM. Lipid prepared from cells exposed to cytotoxic concentrations of ET-18-OCH3 for 18 h also inhibited PIPLC with an IC50 < 1 µM. The noncytotoxic analogue 1-O-alkyl-2-hydroxy-sn-glycero-3-phosphocholine inhibited PIPLC when incorporated into the [3H]PIP2 substrate micelles, but lipid from cells grown with 5 µM 1-O-alkyl-2-hydroxy-sn-glycero-3-phosphocholine did not inhibit PIPLC. BG1 cells, which were more sensitive than Swiss 3T3 fibroblasts to growth inhibition by ET-18-OCH3, had a cytosolic PIPLC activity one-third that of Swiss 3T3 cells. NIH 3T3 cells exhibited the same sensitivity to growth inhibition by ET-18-OCH3 as Swiss 3T3 cells and had a similar level of PIPLC. v-sis NIH 3T3 cells were relatively resistant (>3-fold) to growth inhibition by ET-18-OCH3 and had a cytosolic PIPLC activity more than twice that of the wild type cells. ET-18-OCH3 was a weak inhibitor, IC50 >100 µM, of phospholipase D activity in NIH 3T3 cell membranes. In intact NIH 3T3 cells ET-18-OCH3 at cytotoxic concentrations did not inhibit phospholipase D or phosphatidylcholine-selective phospholipase C activity. The results show that the ether lipid analogues at cytotoxic concentrations are selective inhibitors of PIPLC and that the inhibition of PIPLC may be related to the growth inhibitory activity of the ether lipid analogues.
1 Supported by NIH Grants 42286 and 48725 (G. P.) and CA41314 (E. J. M.).
2 To whom requests for reprints should be addressed, at Arizona Cancer Center, University of Arizona, 1501 North Campbell Ave., Tucson, AZ 85724.
Received 11/12/91. Accepted 3/ 9/92.
This article has been cited by other articles:
![]() |
A. I. Ivanov, A. M. Hopkins, G. T. Brown, K. Gerner-Smidt, B. A. Babbin, C. A. Parkos, and A. Nusrat Myosin II regulates the shape of three-dimensional intestinal epithelial cysts J. Cell Sci., June 1, 2008; 121(11): 1803 - 1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Chen, G. Y.-P. Ko, and S. E. Dryer Somatostatin Peptides Produce Multiple Effects on Gating Properties of Native Cone Photoreceptor cGMP-Gated Channels That Depend on Circadian Phase and Previous Illumination J. Neurosci., November 7, 2007; 27(45): 12168 - 12175. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lei, P.-Y. Deng, J. E. Porter, and H.-S. Shin Adrenergic Facilitation of GABAergic Transmission in Rat Entorhinal Cortex J Neurophysiol, November 1, 2007; 98(5): 2868 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, J. A. Enyeart, and J. J. Enyeart Angiotensin II inhibits native bTREK-1 K+ channels through a PLC-, kinase C-, and PIP2-independent pathway requiring ATP hydrolysis Am J Physiol Cell Physiol, August 1, 2007; 293(2): C682 - C695. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zaika, L. S. Lara, N. Gamper, D. W. Hilgemann, D. B. Jaffe, and M. S. Shapiro Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels J. Physiol., August 15, 2006; 575(1): 49 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nieto-Miguel, C. Gajate, and F. Mollinedo Differential Targets and Subcellular Localization of Antitumor Alkyl-lysophospholipid in Leukemic Versus Solid Tumor Cells J. Biol. Chem., May 26, 2006; 281(21): 14833 - 14840. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. V. Hammond, S. K. Dove, A. Nicol, J. A. Pinxteren, D. Zicha, and G. Schiavo Elimination of plasma membrane phosphatidylinositol (4,5)-bisphosphate is required for exocytosis from mast cells J. Cell Sci., May 15, 2006; 119(10): 2084 - 2094. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Orihuela, A. Parada-Bustamante, L. M Zuniga, and H. B Croxatto Inositol triphosphate participates in an oestradiol nongenomic signalling pathway involved in accelerated oviductal transport in cycling rats. J. Endocrinol., March 1, 2006; 188(3): 579 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reistad and E. Mariussen A Commercial Mixture of the Brominated Flame Retardant Pentabrominated Diphenyl Ether (DE-71) Induces Respiratory Burst in Human Neutrophil Granulocytes In Vitro Toxicol. Sci., September 1, 2005; 87(1): 57 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Horowitz, W. Hirdes, B.-C. Suh, D. W. Hilgemann, K. Mackie, and B. Hille Phospholipase C in Living Cells: Activation, Inhibition, Ca2+ Requirement, and Regulation of M Current J. Gen. Physiol., August 29, 2005; 126(3): 243 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Goggel and S. Uhlig The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema Eur. Respir. J., May 1, 2005; 25(5): 849 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Ramana, B. Friedrich, R. Tammali, M. B. West, A. Bhatnagar, and S. K. Srivastava Requirement of Aldose Reductase for the Hyperglycemic Activation of Protein Kinase C and Formation of Diacylglycerol in Vascular Smooth Muscle Cells Diabetes, March 1, 2005; 54(3): 818 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jun, R. A. Fratti, and W. Wickner Diacylglycerol and Its Formation by Phospholipase C Regulate Rab- and SNARE-dependent Yeast Vacuole Fusion J. Biol. Chem., December 17, 2004; 279(51): 53186 - 53195. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Lin, C. W. Frevert, O. Kajikawa, M. M. Wurfel, K. Ballman, S. Mongovin, V. A. Wong, A. Selk, and T. R. Martin Differential Regulation of Membrane CD14 Expression and Endotoxin-Tolerance in Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 162 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Shafer and C. L. Williams Elevated Rac1 Activity Changes the M3 Muscarinic Acetylcholine Receptor-Mediated Inhibition of Proliferation to Induction of Cell Death Mol. Pharmacol., May 1, 2004; 65(5): 1080 - 1091. [Abstract] [Full Text] |
||||
![]() |
J. C. Todt, B. Hu, and J. L. Curtis The receptor tyrosine kinase MerTK activates phospholipase C {gamma}2 during recognition of apoptotic thymocytes by murine macrophages J. Leukoc. Biol., April 1, 2004; 75(4): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Munsch, M. Freichel, V. Flockerzi, and H.-C. Pape Contribution of transient receptor potential channels to the control of GABA release from dendrites PNAS, December 23, 2003; 100(26): 16065 - 16070. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zamorano, M. D. Rivas, A. Garcia-Trinidad, C.-K. Qu, and A. D. Keegan Phosphatidylcholine-Specific Phospholipase C Activity Is Necessary for the Activation of STAT6 J. Immunol., October 15, 2003; 171(8): 4203 - 4209. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Jackson, D. M. Koterwas, M. A. Morgan, and A. P. Bradford Fibroblast Growth Factors Regulate Prolactin Transcription via an Atypical Rac-Dependent Signaling Pathway Mol. Endocrinol., October 1, 2003; 17(10): 1921 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyata, H. Kashiwadani, M. Fukaya, T. Hayashi, D. Wu, T. Suzuki, M. Watanabe, and Y. Kawakami Role of Thalamic Phospholipase C{beta}4 Mediated by Metabotropic Glutamate Receptor Type 1 in Inflammatory Pain J. Neurosci., September 3, 2003; 23(22): 8098 - 8108. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Meuillet, D. Mahadevan, H. Vankayalapati, M. Berggren, R. Williams, A. Coon, A. P. Kozikowski, and G. Powis Specific Inhibition of the Akt1 Pleckstrin Homology Domain by D-3-Deoxy-Phosphatidyl-myo-Inositol Analogues Mol. Cancer Ther., April 1, 2003; 2(4): 389 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kurrasch-Orbaugh, V. J. Watts, E. L. Barker, and D. E. Nichols Serotonin 5-Hydroxytryptamine2A Receptor-Coupled Phospholipase C and Phospholipase A2 Signaling Pathways Have Different Receptor Reserves J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 229 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. van der Luit, M. Budde, P. Ruurs, M. Verheij, and W. J. van Blitterswijk Alkyl-lysophospholipid Accumulates in Lipid Rafts and Induces Apoptosis via Raft-dependent Endocytosis and Inhibition of Phosphatidylcholine Synthesis J. Biol. Chem., October 11, 2002; 277(42): 39541 - 39547. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sturany, J. Van Lint, A. Gilchrist, J. R. Vandenheede, G. Adler, and T. Seufferlein Mechanism of Activation of Protein Kinase D2(PKD2) by the CCKB/Gastrin Receptor J. Biol. Chem., August 9, 2002; 277(33): 29431 - 29436. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Johnson-Henry, J. L. Wallace, N. S. Basappa, R. Soni, G. K. P. Wu, and P. M. Sherman Inhibition of Attaching and Effacing Lesion Formation following Enteropathogenic Escherichia coli and Shiga Toxin-Producing E. coli Infection Infect. Immun., November 1, 2001; 69(11): 7152 - 7158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sano, X. Zhu, H. Sano, N. M. Munoz, E. Boetticher, and A. R. Leff Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA2 Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L844 - L851. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Strassheim, S. H. Shafer, S. H. Phelps, and C. L. Williams Small Cell Lung Carcinoma Exhibits Greater Phospholipase C-{beta}1 Expression and Edelfosine Resistance Compared with Non-Small Cell Lung Carcinoma Cancer Res., May 1, 2000; 60(10): 2730 - 2736. [Abstract] [Full Text] |
||||
![]() |
M. Llansola, P. Monfort, and V. Felipo Inhibitors of Phospholipase C Prevent Glutamate Neurotoxicity in Primary Cultures of Cerebellar Neurons J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 870 - 876. [Abstract] [Full Text] |
||||
![]() |
Y Shirai, K Kashiwagi, N Sakai, and N Saito Phospholipase A(2) and its products are involved in the purinergic receptor-mediated translocation of protein kinase C in CHO-K1 cells J. Cell Sci., January 4, 2000; 113(8): 1335 - 1343. [Abstract] [PDF] |
||||
![]() |
O. Cuvillier, E. Mayhew, A. S. Janoff, and S. Spiegel Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling Blood, November 15, 1999; 94(10): 3583 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Noll, H. Holschermann, K. Koprek, D. Gunduz, W. Haberbosch, H. Tillmanns, and H. M. Piper ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1892 - H1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Yarovoi, X.-P. Lu, N. Picard, D. Rungta, D. Rideout, and M. Pfahl Selective Activation of an Apoptotic Retinoid Precursor in Macrophage Cell Lines J. Biol. Chem., August 14, 1998; 273(33): 20852 - 20859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Parker, M. S. Parker, T. Sweatman, and W. R. Crowley Characterization of G Protein and Phospholipase C-Coupled Agonist Binding to the Y1 Neuropeptide Y Receptor in Rat Brain: Sensitivity to G Protein Activators and Inhibitors and to Inhibitors of Phospholipase C J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 382 - 391. [Abstract] [Full Text] |
||||
![]() |
I. Baburina and S. Jackowski Apoptosis Triggered by 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine Is Prevented by Increased Expression of CTP:Phosphocholine Cytidylyltransferase J. Biol. Chem., January 23, 1998; 273(4): 2169 - 2173. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, N. R. Murray, and A. P. Fields A Role for Nuclear Phosphatidylinositol-specific Phospholipase C in the G2/M Phase Transition J. Biol. Chem., October 17, 1997; 272(42): 26313 - 26317. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Huber, R Saffrich, M Anton, M Passreiter, W Ansorge, K Gorgas, and W Just A heterotrimeric G protein-phospholipase A2 signaling cascade is involved in the regulation of peroxisomal motility in CHO cells J. Cell Sci., January 12, 1997; 110(23): 2955 - 2968. [Abstract] [PDF] |
||||
![]() |
Z. Cui, M. Houweling, M. H. Chen, M. Record, H. Chap, D. E. Vance, and F. Terce A Genetic Defect in Phosphatidylcholine Biosynthesis Triggers Apoptosis in Chinese Hamster Ovary Cells J. Biol. Chem., June 21, 1996; 271(25): 14668 - 14671. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lemmens, O. Larsson, P.-O. Berggren, and MS Islam Ca2+-induced Ca2+ Release from the Endoplasmic Reticulum Amplifies the Ca2+ Signal Mediated by Activation of Voltage-gated L-type Ca2+ Channels in Pancreatic beta -Cells J. Biol. Chem., March 30, 2001; 276(13): 9971 - 9977. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |